News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

A Takeda Pharmaceutical Co. Ltd. (TKPYY) Manager Asks the Supreme Court to Review a Whistleblower Ruling



8/15/2013 7:23:58 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Will a recent appeals court ruling restrict the ability of whistleblowers to file lawsuits that allege drugmakers duped federal healthcare programs into paying for medicines? This is the contention made by Noah Nathan, a sales manager at Takeda Pharmaceuticals, who claims the drugmaker defrauded Medicare by falsely marketing higher doses of its Kapidex treatment for gastroesophageal reflux disease, or GERD, than what was approved by the FDA. So far, Nathan has lost two rounds in court, but now hopes the US Supreme Court will review his case.

Help employers find you! Check out all the jobs and post your resume.

Read at Pharmalot


comments powered by Disqus
Pharmalot
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES